1. Home
  2. List
Reference Patent

Reference - List

  • 16 Hits
  • Search Condition : Filter (MeSH = Tumor Microenvironment / drug effects)
Species Resource Title
Human and Animal Cells MG-63(RCB1890) Ca2+ -activated K+ channel KCa 1.1 as a therapeutic target to overcome chemoresistance in three-dimensional sarcoma spheroid models.
Human and Animal Cells PC-9(RCB4455) , RERF-LC-AI(RCB0444) 11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.
Human and Animal Cells MMAc·SF(RCB1200) Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells.
Human and Animal Cells PANC-1(RCB2095) Selective cytotoxicity of marine-derived fungal metabolite (3S,6S)-3,6-dibenzylpiperazine-2,5-dione against cancer cells adapted to nutrient starvation.
Human and Animal Cells HeLa Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.
Human and Animal Cells A549(RCB0098) , PANC-1(RCB2095) A Synthetic Analogue of Neopeltolide, 8,9-Dehydroneopeltolide, Is a Potent Anti-Austerity Agent against Starved Tumor Cells.
Human and Animal Cells LM8(RCB1450) , Saos-2(RCB0428) , HOS(RCB0992), , 143B/TK^(-)neo^(R)(RCB0701) Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
Human and Animal Cells HeLa Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.
Human and Animal Cells TE-6(RCB1950) , TE-9(RCB1988) , TE-11(RCB2100) , TE-14(RCB2101) PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment.
Human and Animal Cells UE6E7T-2(RCB2153) Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Human and Animal Cells PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.
Human and Animal Cells OV2944-HM-1(RCB1483) Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.
Human and Animal Cells WA-mFib(RCB1925) , A549(RCB0098) Multicomponent Coculture System of Cancer Cells and Two Types of Stromal Cells for In Vitro Evaluation of Anticancer Drugs.
Human and Animal Cells PK-45P(RCB2141) , PK-1(RCB1972) Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer.
Human and Animal Cells OV2944-HM-1(RCB1483) IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
Human and Animal Cells StromaNKtert(RCB2350) Targeting the pro-survival protein MET with tivantinib (ARQ 197) inhibits growth of multiple myeloma cells.